PharmaSGP Calls Extraordinary General Meeting for Squeeze-out Decision

PharmaSGP Holding SE has announced an extraordinary general meeting set for October 31, 2025, to decide on a squeeze-out procedure. This follows FUTRUE GmbH's notification that it now holds over 95% of PharmaSGP shares, per Section 327a of the German Stock Corporation Act (AktG). The proposed squeeze-out involves transferring remaining shareholder shares to FUTRUE GmbH for a cash compensation of EUR 29.33 per share.

The meeting's goal will be to approve this transfer, which requires a general meeting pass and registration with the commercial register. A detailed valuation process has informed this decision. Additional information and relevant documents are available on PharmaSGP's website.